Azenta Inc (AZTA)
50.43
-0.06
(-0.12%)
USD |
NASDAQ |
Apr 19, 15:49
Azenta Revenue (TTM): 641.02M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 641.02M |
September 30, 2023 | 665.07M |
June 30, 2023 | 630.28M |
March 31, 2023 | 597.07M |
December 31, 2022 | 594.21M |
September 30, 2022 | 555.50M |
June 30, 2022 | 554.87M |
March 31, 2022 | 551.22M |
December 31, 2021 | 535.21M |
September 30, 2021 | 513.70M |
June 30, 2021 | 114.22M |
March 31, 2021 | 205.49M |
December 31, 2020 | 296.18M |
September 30, 2020 | 388.54M |
June 30, 2020 | 403.62M |
March 31, 2020 | 387.15M |
December 31, 2019 | 365.31M |
September 30, 2019 | 334.18M |
June 30, 2019 | 741.28M |
March 31, 2019 | 709.77M |
December 31, 2018 | 668.33M |
September 30, 2018 | 631.56M |
June 30, 2018 | 488.41M |
March 31, 2018 | 497.76M |
December 31, 2017 | 510.14M |
Date | Value |
---|---|
September 30, 2017 | 527.50M |
June 30, 2017 | 542.25M |
March 31, 2017 | 508.06M |
December 31, 2016 | 474.01M |
September 30, 2016 | 434.01M |
June 30, 2016 | 548.54M |
March 31, 2016 | 545.90M |
December 31, 2015 | 549.93M |
September 30, 2015 | 552.71M |
June 30, 2015 | 529.46M |
March 31, 2015 | 501.92M |
December 31, 2014 | 488.51M |
September 30, 2014 | 482.85M |
June 30, 2014 | 471.01M |
March 31, 2014 | 464.42M |
December 31, 2013 | 448.01M |
September 30, 2013 | 428.96M |
June 30, 2013 | 407.26M |
March 31, 2013 | 436.92M |
December 31, 2012 | 466.78M |
September 30, 2012 | 488.98M |
June 30, 2012 | 530.95M |
March 31, 2012 | 576.65M |
December 31, 2011 | 629.97M |
September 30, 2011 | 688.10M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
114.22M
Minimum
Jun 2021
741.28M
Maximum
Jun 2019
477.59M
Average
535.21M
Median
Dec 2021
Revenue (TTM) Benchmarks
Revvity Inc | 2.751B |
Bruker Corp | 2.964B |
Harvard Bioscience Inc | 112.25M |
Bionano Genomics Inc | 36.12M |
Akoya Biosciences Inc | 96.63M |